Opinion
Video
The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity
A panel of experts examines the impact of cardiometabolic diseases in the United States, focusing on their burden, prevalence, and relationship to obesity.
Video content above is prompted by the following:
- What is the clinical and economic burden of Cardiorenal Metabolic Disease (CRM) conditions such as type 2 diabetes, chronic kidney disease, cardiovascular disease and heart failure in the United States?
- How do CRM conditions affect patient quality of life and clinical outcomes?
- How do these conditions impact healthcare resource utilization?
- The CDC has announced that over 42% of adults have obesity; what role does obesity play in the prevalence of CRM conditions in the United States?
- Is this your experience in your practice?
This activity is supported by an educational grant from Boehringer Ingelheim.
Related Videos
Related Content
